By Stephen Bishop, MBA, MS, CLS, MLS(ASCP)CM, CPHQ
LEARNING OBJECTIVES
Upon completion of this article, the reader will be able to:
- Discuss the utility for the advancement of respiratory pathogen diagnosis.
- Discuss timelines of respiratory illnesses and the development of laboratory testing with each.
- Define the limitations of antigen testing in the identification of respiratory pathogens.
- Describe the different subsets of AI and each of their purposes in the use of respiratory pathogens identification.

Stephen Bishop, MBA, MS, CLS, MLS(ASCP)CM, CPHQ is currently the Market Director of Laboratory Services at CommonSpirit Health, Southern California. Stephen is passionate about healthcare leadership, clinical laboratory education, and process improvement.
Test smarter, not harder: Boosting quality and reducing avoidable costs through laboratory stewardship
Beyond the bench: How artificial intelligence is redefining respiratory pathogen diagnostics in the clinical laboratory
Evolving paradigms in diabetes diagnosis and classification
Cancer biomarker types and clinical applications
Advancements in techniques and technologies in oncology

